B Payrastre Selected Research

B Payrastre Research Topics

Disease

4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2011 - 04/2008
4	Neoplasms (Cancer) 01/2011 - 07/2001
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2013 - 05/2006
2	Thrombocytopenia (Thrombopenia) 10/2011 - 11/2000
2	Congenital Structural Myopathies (Centronuclear Myopathy) 10/2003 - 09/2000
1	Acute Coronary Syndrome 01/2018
1	Cytopenia 01/2018
1	Hematuria 01/2018
1	Hemorrhage 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018
1	Tangier Disease 03/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2013
1	Leukemia 02/2012
1	Thrombophilia 10/2011
1	Scott Syndrome 10/2011
1	Neoplasm Metastasis (Metastasis) 06/2011
1	Disease Progression 06/2011
1	Lymphoma (Lymphomas) 06/2011
1	Carcinogenesis 07/2008
1	Atherosclerosis 06/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2003
1	Acute Erythroblastic Leukemia (Erythroleukemia) 10/2001
1	Hepatocellular Carcinoma (Hepatoma) 07/2001
1	Insulin Resistance 04/2001

Drug/Important Bio-Agent (IBA)

4	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2011 - 04/2008
4	Anaplastic Lymphoma KinaseIBA 06/2011 - 04/2008
3	Proteins (Proteins, Gene)FDA Link 10/2011 - 10/2003
2	Heparin (Liquaemin)FDA LinkGeneric 10/2011 - 11/2000
2	LipidsIBA 07/2008 - 04/2001
2	myotubularinIBA 10/2003 - 09/2000
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2001 - 09/2000
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018
1	von Willebrand FactorIBA 01/2018
1	AnticoagulantsIBA 01/2018
1	Biological ProductsIBA 01/2018
1	CollagenIBA 01/2018
1	Inosine Triphosphate (ITP)IBA 01/2018
1	SuspensionsIBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2016
1	HDL LipoproteinsIBA 03/2016
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2016
1	CholesterolIBA 03/2016
1	tyrosine receptor (receptor, tyrosine)IBA 02/2013
1	Phosphotransferases (Kinase)IBA 02/2013
1	Pharmaceutical PreparationsIBA 02/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2011
1	Thromboplastin (Tissue Factor)IBA 10/2011
1	Immunoglobulin G (IgG)IBA 10/2011
1	CalciumIBA 10/2011
1	AntibodiesIBA 10/2011
1	Monomeric GTP-Binding ProteinsIBA 06/2011
1	GTP Phosphohydrolases (GTPases)IBA 06/2011
1	LipoxygenasesIBA 07/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2009
1	Protein Isoforms (Isoforms)IBA 07/2009
1	phosphatidylinositol 5-phosphateIBA 07/2008
1	p80(NPM-ALK) proteinIBA 04/2008
1	Estrogens (Estrogen)FDA Link 06/2007
1	beta CateninIBA 07/2006
1	Phosphoinositide PhosphatasesIBA 10/2003
1	Transcription Factors (Transcription Factor)IBA 10/2001
1	Erythropoietin FDA Link 10/2001
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2001
1	ResveratrolIBA 07/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 07/2001
1	PolyphenolsIBA 07/2001
1	Inositol Polyphosphate 5-PhosphatasesIBA 04/2001
1	PhosphotyrosineIBA 04/2001
1	Insulin (Novolin)FDA Link 04/2001
1	Fc gamma receptor IIAIBA 11/2000
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2000
1	phosphatidylinositol 3-phosphateIBA 09/2000

Therapy/Procedure

5	Therapeutics 02/2012 - 06/2007
1	Drug Therapy (Chemotherapy) 05/2006